Biotech Values

[DewDiligence]

ZGEN – Below are annualized worldwide sales and
market-share figures for Pegasys, Pegintron, and
(non-pegylated) Intron-A. (Sales of Intron-A are
almost entirely from outside the US.) These are
1Q08 figures, but little has changed since then in
the interferon-alpha market and hence the numbers
are still accurate enough for investment purposes.

 
            Sales   Market 
             ($B)   Share 
 Pegasys     1.03    56%  
 Pegintron   0.90    35%  
 Intron-A    0.22     9%  
 =========   ====   ==== 
 Total       2.15   100%

Source: Roche, Schering-Plough